Acquired factor VIII inhibitors.
暂无分享,去创建一个
[1] Hsin-Hua Chen,et al. Systemic Lupus Erythematosus Develop Seven Years after Acquisition of Acquired Hemophilia a in a Patient with Palindromic Rheumatism: A Case Report , 2009 .
[2] C. Kessler,et al. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A , 2009, Haematologica.
[3] G. Lippi,et al. Acquired factor VIII inhibitors in oncohematology: a systematic review. , 2008, Critical reviews in oncology/hematology.
[4] B. Garvey. Rituximab in the treatment of autoimmune haematological disorders , 2008, British journal of haematology.
[5] C. Kempton,et al. A Phase II Open-Label Study Evaluating Hemostatic Activity, Pharmacokinetics and Safety of Recombinant Porcine Factor VIII (OBI-1) in Hemophilia A Patients with Alloantibody Inhibitors Directed Against Human FVIII. , 2007 .
[6] P. Sen,et al. Activity and Regulation of Long-Acting Factor VIIa Analogs. , 2007 .
[7] T. Weimer,et al. Prolonged In-Vivo Half-Life of FVIIa by Fusion to Albumin. , 2007 .
[8] S. Seremetis,et al. Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.
[9] M. Franchini,et al. The management of hemophilia in elderly patients , 2007, Clinical interventions in aging.
[10] D. DiMichele. Immune tolerance therapy for factor VIII inhibitors: moving from empiricism to an evidence‐based approach , 2007, Journal of thrombosis and haemostasis : JTH.
[11] M. Franchini. Rituximab in the treatment of adult acquired hemophilia A: a systematic review. , 2007, Critical reviews in oncology/hematology.
[12] G. Lippi,et al. Drug-induced anti-factor VIII antibodies: a systematic review. , 2007, Medical science monitor : international medical journal of experimental and clinical research.
[13] T. Baglin,et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. , 2007, Blood.
[14] C. Hausl,et al. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors , 2007, British journal of haematology.
[15] D. Green. The management of acquired haemophilia , 2006 .
[16] M. Franchini. Postpartum acquired factor VIII inhibitors , 2006, American journal of hematology.
[17] G. Lippi,et al. The efficacy of rituximab in the treatment of inhibitor-associated hemostatic disorders , 2006, Thrombosis and Haemostasis.
[18] A. Onitilo,et al. Rituximab in the treatment of acquired factor VIII inhibitors , 2006, Thrombosis and Haemostasis.
[19] L. Mouthon,et al. Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two cases , 2006, Transfusion medicine.
[20] R. Liesner,et al. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation , 2006, British journal of haematology.
[21] J. Ingerslev,et al. Acquired haemophilia: dynamic whole blood coagulation utilized to guide haemostatic therapy , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.
[22] E. Hachulla,et al. Rituximab in postpartum-related acquired hemophilia. , 2006, The American journal of medicine.
[23] J. Ingerslev,et al. Tailoring haemostatic treatment to patient requirements – an update on monitoring haemostatic response using thrombelastography , 2005, Haemophilia : the official journal of the World Federation of Hemophilia.
[24] G. Tjønnfjord,et al. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies , 2005, Haemophilia : the official journal of the World Federation of Hemophilia.
[25] G. Mariani,et al. Acquired hemophilia A: A concise review , 2005, American journal of hematology.
[26] J. Maize,et al. Cyclosporine controls epidermolysis bullosa acquisita co‐occurring with acquired factor VIII deficiency , 2005, International journal of dermatology.
[27] H. Vetter,et al. Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept. , 2005, Blood.
[28] L. Aledort,et al. Treatment of patients with acquired inhibitors , 2005, Journal of thrombosis and haemostasis : JTH.
[29] L. Boggio,et al. Rituximab for autoimmune haemophilia: a proposed treatment algorithm , 2005, Haemophilia : the official journal of the World Federation of Hemophilia.
[30] D. Girelli,et al. Clinical heterogeneity of acquired hemophilia A: a description of 4 cases. , 2005, Haematologica.
[31] Dougald M Monroe,et al. The use of recombinant factor VIIa in the treatment of bleeding disorders. , 2004, Blood.
[32] P. Saidi,et al. Acquired factor VIII inhibitors in non‐haemophilic patients: clinical experience of 15 cases , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.
[33] S. Darby,et al. The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977–99 , 2004, Journal of thrombosis and haemostasis : JTH.
[34] S. Amadori,et al. Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia. , 2004, Blood.
[35] G. Kenet,et al. Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors , 2004, Journal of thrombosis and haemostasis : JTH.
[36] S. Sallah. Treatment of acquired haemophilia with factor eight inhibitor bypassing activity , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.
[37] Y. Kwong,et al. Successful treatment of acquired factor VIII inhibitor with cyclosporin , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.
[38] P. Collins,et al. A population based, unselected, consecutive cohort of patients with acquired haemophilia A , 2004, British journal of haematology.
[39] G. Gaidano,et al. Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia. , 2004, Haematologica.
[40] L. Horstman,et al. Life-Threatening Bleeding from Refractory Acquired FVIII Inhibitor Successfully Treated with Rituximab , 2003, Acta Haematologica.
[41] J. Delgado,et al. Acquired Haemophilia: Review and Meta‐Analysis Focused on Therapy and Prognostic Factors , 2003, British journal of haematology.
[42] A. Engert,et al. An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[43] J. Wan,et al. Efficacy of 2-chlorodeoxyadenosine in refractory factor VIII inhibitors in persons without hemophilia. , 2003, Blood.
[44] Sam Kain,et al. Treatment of refractory autoimmune (acquired) haemophilia with anti‐cd20 (rituximab) , 2002, British journal of haematology.
[45] H. Roberts,et al. Platelet-dependent action of high-dose factor VIIa. , 2002, Blood.
[46] M. Ragni,et al. Acquired anti‐FVIII inhibitors in children , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.
[47] J. Wan,et al. Inhibitors against Factor VIII Associated with the Use of Interferon-alpha and Fludarabine , 2001, Thrombosis and Haemostasis.
[48] H. Watson,et al. Acquired haemophilia in association with organ‐specific autoimmune disease , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.
[49] Y. Gruel,et al. Acquired inhibitor to factor VIII in a patient with Hodgkin’s disease following treatment with interferon‐alpha , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.
[50] R. Saxena,et al. Postpartum acquired haemophilia: clinical recognition and management , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.
[51] J. Wan,et al. Inhibitors against factor VIII in patients with cancer , 2001, Cancer.
[52] I. Walker,et al. Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: a 2‐year review , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.
[53] W. Hörl,et al. Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig‐Therasorb) , 2001, British journal of haematology.
[54] L. Boggio,et al. Acquired hemophilia. , 2001, Reviews in clinical and experimental hematology.
[55] E. Pitlik,et al. New protocol for immune tolerance induction in acquired hemophilia. , 2000, Haematologica.
[56] D. Keeling,et al. THE DIAGNOSIS and MANAGEMENT OF FACTOR VIII and IX INHIBITORS: A GUIDELINE FROM THE UK HAEMOPHILIA CENTRE DOCTORS' ORGANIZATION (UKHCDO) , 2000, British journal of haematology.
[57] N. Nguyen,et al. Acquired hemophilia in patients with hematologic malignancies. , 2000, Archives of pathology & laboratory medicine.
[58] E. Derom,et al. Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies. , 2000, Haematologica.
[59] K. Derfler,et al. Extracorporeal Immunoadsorption for the Treatment of Haemophilic Patients with Inhibitors to Factor VIII or IX , 1999, Vox Sanguinis.
[60] F. Trotta,et al. Long-lasting remission and successful treatment of acquired factor VIII inhibitors using cyclophosphamide in a patient with systemic lupus erythematosus. , 1999, Rheumatology.
[61] K. Lechner,et al. Solid Tumors and Factor VIII Antibodies , 1999, Thrombosis and Haemostasis.
[62] K. Pasi,et al. Factor VIII inhibitors in haemophiliacs: a single‐centre experience over 34 years, 1964–97 , 1999, British journal of haematology.
[63] G. Lippi,et al. A combination of prednisone, high-dose intravenous immunoglobulin and desmopressin in the treatment of acquired hemophilia A with high-titer inhibitor. , 1999, Haematologica.
[64] J. Pouchot,et al. Acquired hemophilia due to factor VIII inhibitors in 34 patients. , 1998, The American journal of medicine.
[65] S. Solymoss. Postpartum acquired factor VIII inhibitors: Results of a survey , 1998, American journal of hematology.
[66] C. Hay. 1 Acquired haemophilia , 1998 .
[67] C. Négrier,et al. The Treatment of Bleeding in Acquired Haemophilia with Recombinant Factor VIIa: A Multicentre Study , 1997, Thrombosis and Haemostasis.
[68] C. Fabbri,et al. Acquisition of factor VIII inhibitor after acute hepatitis C virus infection. , 1997, Blood.
[69] L. Shaffer,et al. Successful Treatment of Acquired Hemophilia with Oral Immunosuppressive Therapy , 1997, Annals of Internal Medicine.
[70] H. Nieuwenhuis,et al. Acquired haemophilia A in women postpartum: management of bleeding episodes and natural history of the factor VIII inhibitor , 1997, European journal of haematology.
[71] G. Kobbe,et al. Acquired factor VIII inhibitors in nonhemophilic patients , 1997, Annals of Hematology.
[72] J. Ducobu,et al. Low response to high‐dose intravenous immunoglobulin in the treatment of acquired factor VIII inhibitor , 1996, British journal of haematology.
[73] S. Schulman,et al. Cyclosporine Therapy for Acquired Factor VIII Inhibitor in a Patient with Systemic Lupus Erythematosus , 1996, Thrombosis and Haemostasis.
[74] R. Chamuleau,et al. Formation of Antibodies to Factor VIII in Patients with Hemophilia A Who Are Treated with Interferon for Chronic Hepatitis C , 1996, Annals of Internal Medicine.
[75] C. Kessler,et al. 9 Acquired inhibitors , 1996 .
[76] M. Surks,et al. Graves' disease and autoimmune factor VIII deficiency. , 1996, Thyroid : official journal of the American Thyroid Association.
[77] S. Ennis,et al. Cloning of the bovine activin receptor type II gene (ACVR2) and mapping to chromosome 2 (BTA2). , 1996, Cytogenetics and cell genetics.
[78] C. Kessler,et al. Acquired inhibitors. , 1996, Bailliere's clinical haematology.
[79] P. Mannucci,et al. Safety Profile of Porcine Factor VIII and Its Use as Hospital and Home-Therapy for Patients with Haemophilia-A and Inhibitors: the Results of An International Survey , 1996, Thrombosis and Haemostasis.
[80] S. Raman,et al. Disappearance of factor VIII antibody after removal of primary colon adenocarcinoma , 1995, American journal of hematology.
[81] C. Kessler,et al. A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin. , 1995, Blood.
[82] C. Ludlam,et al. ACQUIRED HAEMOPHILIA AND ITS MANAGEMENT , 1995, British journal of haematology.
[83] K. Lechner,et al. Post-Partum Factor VIII Inhibitors , 1995, Thrombosis and Haemostasis.
[84] C. Kessler,et al. Treatment of acquired hemophilia. , 1994, Seminars in hematology.
[85] A. Rademaker,et al. A Prospective, Randomized Trial of Prednisone and Cyclophosphamide in the Treatment of Patients with Factor VIII Autoantibodies , 1993, Thrombosis and Haemostasis.
[86] W. Kane,et al. DDAVP in acquired hemophilia a: Case report and review of the literature , 1993, American journal of hematology.
[87] C. Kessler,et al. Use of porcine factor VIII in the treatment of patients with acquired hemophilia. , 1993, Blood.
[88] M. Hultin. Acquired inhibitors in malignant and nonmalignant disease states. , 1991, The American journal of medicine.
[89] C. Négrier,et al. Successful treatment of acquired factor VIII antibody by extracorporeal immunoadsorption. , 1991, Acta haematologica.
[90] S. Mehta,et al. Acquired haemophilia. , 1990, The Journal of the Association of Physicians of India.
[91] C. Fulcher,et al. Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralization. , 1989, Blood.
[92] D. Brettler,et al. The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience. , 1989, Archives of internal medicine.
[93] A. Y. Chiu,et al. Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. , 1989, Annals of internal medicine.
[94] J. M. Matthews,et al. Acquired haemophilia and rheumatoid arthritis. , 1987, British journal of rheumatology.
[95] C. Kitchens,et al. Acquired Hemophilia: A Natural History Study of 16 Patients With Factor VIII Inhibitors Receiving Little or No Therapy , 1987 .
[96] J. Roberts,et al. Localization of human factor FVIII inhibitor epitopes to two polypeptide fragments. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[97] M. Kazatchkine,et al. ANTI-IDIOTYPIC SUPPRESSION OF AUTOANTIBODIES TO FACTOR VIII (ANTIHAEMOPHILIC FACTOR) BY HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN , 1984, The Lancet.
[98] E. Tuddenham,et al. Clinical experience with polyelectrolyte-fractionated porcine factor VIII concentrate in the treatment of hemophiliacs with antibodies to factor VIII. , 1984, Blood.
[99] P. Höcker,et al. Plasmapheresis: its value in the management of patients with antibodies to factor VIII. , 1982, Haemostasis.
[100] A. Burnett,et al. Plasma exchange in non-haemophiliac patients with inhibitors to factor VIIIC. , 1981, British medical journal.
[101] J. Lewis,et al. Corticosteroid Therapy for Acquired F VIII:C Inhibitors , 1981, British journal of haematology.
[102] K. Lechner,et al. A Survey of 215 Non-Hemophilic Patients with Inhibitors to Factor VIII , 1981, Thrombosis and Haemostasis.
[103] G. White,et al. Treatment of Anti-Factor VIII Antibodies , 1977, Thrombosis and Haemostasis.
[104] E. Bowie,et al. Treatment of life-threatening hemorrhage due to acquired factor VIII inhibitor. , 1975, Blood.
[105] D. Green. FACTOR VIII ANTIBODIES: IMMUNOSUPPRESSIVE THERAPY * , 1975, Annals of the New York Academy of Sciences.
[106] R. Biggs,et al. The Mode of Action of Antibodies which Destroy Factor VIII , 1972, British journal of haematology.
[107] D. Green. Suppression of an antibody to factor VIII by a combination of factor VIII and cyclophosphamide. , 1971, Blood.
[108] D. Jackson,et al. CIRCULATING ANTICOAGULANTS: A STUDY OF 40 CASES AND A REVIEW OF THE LITERATURE , 1961, Medicine.